-
D-Street shrugs off Covid woes, here’s how markets may trade on Thursday
The rally has surprised most traders and fund managers, who were expecting the market to slide given the restrictions announced by many state governments in light of the impact of the second wave of COVID-19.
Sakshi BatraApril 28, 2021/7:59 PM IST -
CoWIN Portal: More than 35 lakh registered in the first hour, after minor server crash
As per the government sources, more than 35 lakh people have registered on CoWIN site after 4 pm. The sources said that the appointments have been based on the slots made available by states and private vaccination centers.
Money9April 28, 2021/7:46 PM IST -
Remdesivir not a life-saving injection: Top doctor from Maha Covid-19 Task Force
Several top doctors in the country have repeatedly advised not to take Remdesivir as a precautionary medicine at home
Priyanka SambhavApril 28, 2021/7:45 PM IST -
Five pulse oximeters under Rs 2,500
If you have a pulse oximeter at home, it can monitor the oxygen levels of infected patients at regular intervals
Noopur PraveenApril 28, 2021/7:44 PM IST -
Covid-19 impact: Prices of oximeter, inhaler and other medical devices hit the roof
Local medical shops are also struggling to refill stocks of medicines
Money9April 28, 2021/7:43 PM IST -
COVID-19 pandemic laid threadbare issue of digital divide: Ravi Shankar Prasad
Kerala currently supplies medical oxygen to Karnataka, Tamil Nadu, Delhi and Goa
Press Trust of IndiaApril 28, 2021/7:08 PM IST -
COVID-19: April toll crosses earlier record
The Health Ministry keeps emphasising that the fatality rate is as low as 1.1%
Ankur SenguptaApril 28, 2021/7:06 PM IST -
What was the fallout of the Harshad Mehta-headlined Securities scam? Revisit the episode that rocked Indian financial markets
A look at how changes were done to safeguard investors following the unearthing of the Securities scam
Sakshi BatraApril 28, 2021/6:46 PM IST -
Covishield: Serum Institute of India slashes price for states from Rs 400 to Rs 300 per dose
Adar Poonawalla in a tweet said that the company has taken a philanthropic decision to reduce the price of Covishield for states to Rs 300 dose effective immediately
Money9April 28, 2021/6:07 PM IST
